Watch ATRC. Know when insiders buy.
One email the day a filing lands. Free.
Work order
37
FLAG · insiders 27, shorts 46
Insiders, 90 days
−$866K
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.6BP/E 245.3DIV YIELD —FCF YIELD 2.03%REV TTM $569.6M +13.9%NET INCOME $10.6MNET CASH $106.8M52W 25.86 – 52.59SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $153.6M | +12.8% | 77.2% | $9.7M | $9M | — | 0.18 | $22.2M | $3.8M | $18.4M | Jul 27 |
| Q1 2026 · Mar 31 | $141.2M | +14.3% | 77.4% | $526K | $108K | — | 0.00 | −$4M | $3.9M | −$7.8M | May 6 |
| Q4 2025 · Dec 31derived | $140.5M | +13.1% | 75.0% | $2.5M | $1.8M | — | 0.04 | $20M | $1.6M | $18.4M | Feb 19 |
| Q3 2025 · Sep 30 | $134.3M | +15.8% | 75.5% | $208K | −$267K | — | -0.01 | $26.7M | $2.6M | $24.1M | Oct 30 |
| Q2 2025 · Jun 30 | $136.1M | +17.1% | 74.5% | −$6.2M | −$6.2M | — | -0.13 | $21.6M | $2.7M | $19M | Jul 27 |
| Q1 2025 · Mar 31 | $123.6M | +13.6% | 74.9% | −$6M | −$6.7M | — | -0.14 | −$11M | $2.2M | −$13.2M | May 6 |
| Q4 2024 · Dec 31derived | $124.3M | +16.6% | 74.5% | −$14.5M | −$15.6M | — | -0.33 | $5.8M | $2.7M | $3.1M | Feb 19 |
| Q3 2024 · Sep 30 | $115.9M | +17.9% | 74.9% | −$7.4M | −$7.9M | — | -0.17 | $20M | $3.6M | $16.4M | Oct 30 |
| Q2 2024 · Jun 30 | $116.3M | — | 74.7% | −$7.2M | −$8M | — | -0.17 | $7.4M | $2.4M | $5M | Jul 30 |
| Q1 2024 · Mar 31 | $108.9M | — | 74.7% | −$10.9M | −$13.3M | — | -0.28 | −$21M | $2.8M | −$23.8M | Apr 30 |
| Q4 2023 · Dec 31derived | $106.5M | — | 74.9% | −$8.7M | −$9.8M | — | -0.21 | $4M | $2.8M | $1.2M | Feb 19 |
| Q3 2023 · Sep 30 | $98.3M | — | 75.2% | −$8.1M | −$9.1M | — | -0.20 | $1.5M | $3.6M | −$2.1M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $534.5M | 75.0% | −$9.4M | −$11.4M | -2.1% | -0.24 | $57.3M | $9.1M | $48.3M | — | — |
| FY2024 · to Dec 31 | $465.3M | 74.7% | −$40M | −$44.7M | -9.6% | -0.95 | $12.2M | $11.5M | $745K | — | — |
| FY2023 · to Dec 31 | $399.2M | 75.2% | −$26.7M | −$30.4M | -7.6% | -0.66 | $4.5M | $12M | −$7.5M | — | — |
| FY2022 · to Dec 31 | $330.4M | 74.4% | −$42.7M | −$46.5M | -14.1% | -1.02 | −$22.1M | $16.9M | −$39M | — | — |
| FY2021 · to Dec 31 | $274.3M | 75.0% | $55.2M | $50.2M | 18.3% | 1.09 | −$13.8M | $9.8M | −$23.5M | — | — |
| FY2020 · to Dec 31 | $206.5M | 72.3% | −$44.2M | −$48.2M | -23.3% | -1.14 | −$19.9M | $5.3M | −$25.1M | — | — |
Every number comes from AtriCure, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.